Fixed Pigmented Erythema Related to Terbinafine: A Case Report

Main Article Content

Estefhaníe Villalba Leiva
Jaime Andrés Benítez Kellendonk
Ana María Kellendonk
William Portilla

Abstract

The fixed drug erythema is a special variant of toxicodermia characterized by the appearance of post-drug administration skin lesions; diagnosis is primarily clinical, through a detailed medical history with emphasis on the description of drugs used. Within this group of drugs is terbinafine, an antifungal often used to treat minor ailments and for a prolonged period. The main adverse drug reactions are the alteration or loss of taste and appearance compatible with hypersensitivity reactions rash or photosensitivity. We report the case of a patient who presented to Dermatology department of the Hospital Un Canto a la Vida, located in the south of Quito, with an erythematous plaque located in the left thigh with several months of evolution. A detailed history was made with a greater interest in the administration of any medication previously, being positive the use of terbinafine. Different complementary tests were performed and it was determined that the patient had a fixed drug reaction associated with the use of terbinafine. The study of this case is of great interest because it can be a diagnostic challenge for the physician.

Downloads

Download data is not yet available.

Article Details

How to Cite
LeivaE. V., KellendonkJ. A. B., KellendonkA. M., & PortillaW. (2015). Fixed Pigmented Erythema Related to Terbinafine: A Case Report. AXIOMA, 2(13), 18-24. Retrieved from https://pucesinews.pucesi.edu.ec/index.php/axioma/article/view/428
Section
INVESTIGACIÓN
Author Biographies

Estefhaníe Villalba Leiva, Médico Cirujana. RedMédica

Médico Cirujana. RedMédica

Jaime Andrés Benítez Kellendonk, Médico Cirujano. Hospital de SOLCA

Médico Cirujano. Hospital de SOLCA

 

Ana María Kellendonk, Dermatóloga. Hospital Un Canto a la Vida

Dermatóloga. Hospital Un Canto a la Vida

William Portilla, Patólogo. Hospital Un Canto a la Vida

Patólogo. Hospital Un Canto a la Vida

References

Agusti-Mejias, A., Mejias-Boils, A., Messeguer, F. y Alegre De Miquel, V. (2011). Eritema fijo medicamentoso: claves diagnósticas. Medicina de Familia. SEMERGEN, 37(4), 215-218.
Alonzo, L. y López Cepeda, L. D. (2000). Diagnóstico diferencial de reacciones medicamentosas adversas. Revista del Centro Dermatológico Pascua, 9(2), 120-125.
Aquino, C. y Jurado Santa Cruz, F. (2009). Interacciones medicamentosas en dermatología. Dermatología Revista Mexicana, 53(3), 125-140.
Darwich, E. y Fuertes de Vega, I. (16 de Octubre de 2008). Diagónstico a primera vista. Obtenido de http://www.jano.es/ficheros/sumarios/1/0/1710/39/00390039_LR.pdf
Echavarría, L., Mejía Camacho, D., Vargas Velázquez, J. J., Casas Mercado, R. y Muñoz Estrada, V. F. (2001). Estudio Epidemiológico, clínico y etiológico del Eritema Pigmentado Fijo, serie de 64 casos. CIMEL Ciencia e Investigación Médica Estudiantil Latinoamericana(6), 44-48.
Lázaro, P. y Avilés Izquierdo, J. (24 de Septiembre de 2004). JANO.es. Obtenido de http://www.jano.es/ficheros/sumarios/1/67/1534/66/1v67n1534a13067001pdf001.pdf
Muñoz, V. y Valenzuela Paz, G. A. (2011). Eritema pigmentado fijo genital. Estudio de 69 casos. Revista del Centro Dermatológico Pascua, 20(3), 91-99.
Muñoz, V., Valenzuela Paz, G. y Rochín, M. (2011). Estudio de 372 casos de eritema fijo pigmentario. Piel, 26(5), 213-220.
Padmavathi, S., Manimekalai, K. y Ambujam, S. (2013). Causality, Severity and Preventability Assessment of Adverse Cutaneous Drug Reaction: A Prospective Observational Study in a Tertiary Care Hospital. Journal of Clinical and Diagnostic Research, 7(12), 2765-2767.
Revista Panamericana de Salud Pública (1997). Reacciones adversas. l(4), 308-310. ISSN 1020-4989. Recuperado de http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997000400018&lng=pt&tlng=es. 10.1590/S1020-49891997000400018
Ríos Yuil, J. M. y Ríos Castro, M. (2011). El concepto P-i: Una nueva teoría inumonológica sobre las reacciones cutáneas asociadas a fármacos. Revista Médico Científica, 24(1), 20-32.